Skip to content

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

SPLUNC1/BPIFA1 Restrains Neutrophil-Dominant Inflammation and Coordinated Inflammatory Gene Programs During LPS-Induced Lung Injury

Acute lung injury (ALI) is characterized by alveolar-capillary barrier disruption, increased pulmonary permeability, impaired gas exchange, and inflammation. Lipopolysaccharide (LPS), a potent microbial trigger of inflammation, is widely used to model ALI. Short palate, lung, and nasal epithelial clone 1 (SPLUNC1), als...

He-Xin Lu, Y. Di · 0 citations
Sep 2026

Unveiling the antiviral mechanism of A4S7: a synthetic antimicrobial peptide targeting dengue and other mosquito-borne enveloped virus infections.

The synthetic AMP A4S7 was investigated, which effectively inhibited DENV-2 RNA and protein expression and reduced viral progeny production at specified concentrations without exhibiting cytotoxicity in Vero cells, and found the α-helical structure of A4S7 was found to be crucial for its antiviral activity.

Ting-Chun Lin, Jeng-Wei Lu, Chia-Hsin Liu et al. · 0 citations
Review Open access Sep 2026

Inhalable Dry Powders of Antimicrobial Agents in Respiratory Diseases

Respiratory infections remain a major global health burden despite advances in systemic antimicrobial therapy. Antimicrobial dry powder inhalers (DPIs) have emerged as precision-engineered pulmonary delivery platforms capable of achieving high local drug concentrations while minimizing systemic toxicity. This review ex...

Hasham Shafi, David Encinas-Basurto, Y. Di et al. · 0 citations
Review Open access Sep 2026

Anticancer Peptides: Design Principles, Translational Bottlenecks, and Emerging Opportunities

Anticancer peptides (ACPs) are frequently discussed as a single therapeutic class, yet the term encompasses molecules that perform markedly different jobs: direct tumor-cell killing, intracellular target modulation, tumor homing and penetration, or selective delivery of a separate payload. This functional diversity cre...

Marissa E. Di, Y. Di · 0 citations
Open access Aug 2026

Mechanistic Insights into CFTR Potentiation by the Antimicrobial Peptide Esc(1–21): Direct Interaction with the NBD1-NBD2 Interface

The first mechanistic insights into the interaction of Esc(1–21) with CFTR in a cellular context are provided and the NBD1-NBD2 interface is identified as a suitable target for peptide-based potentiators to support the development of Esc(1–21) and its derivatives as novel multifunctional therapeutic candidates for CF t...

D. Baroni, L. Ferrera, Mario Passalacqua et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.